Infectious Risks and Optimal Strength of Maintenance Immunosuppressants in Rituximab-Treated Kidney Transplantation

BACKGROUND: Rituximab, an anti-CD20 antibody, effectively depletes B lymphocytes. It is not clear whether the use of conventional doses of mycophenolate mofetil (MMF), methylprednisolone and tacrolimus as maintenance immunosuppression in rituximab-treated kidney transplantation is associated with in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Baek, Chung Hee, Yang, Won Seok, Park, Kyung Sun, Han, Duck Jong, Park, Jae Berm, Park, Su-Kil
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2012
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350352/
https://ncbi.nlm.nih.gov/pubmed/22619669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000337339
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares